Streetbeat News

Earnings

FIVE

MU

QQQ

SCS

SPY

U.S. stocks are poised for further gains, buoyed by optimism following the Fed's dovish stance and anticipation of rate cuts. The rally is broadening beyond tech stocks, with small-caps and various sectors showing strength. Key economic data and earnings reports are in focus. Futures indicate a positive opening, with SPY and QQQ ETFs up in premarket trading. Micron Technology surged on earnings, while Steelcase and Five Below declined. Other notable earnings include Accenture, Darden Restaurants, Winnebago, Shoe Carnival, FedEx, Lululemon, NIKE, and Worthington Steel.

Portfolio Pulse from Shanthi Rexaline

March 21, 2024 | 11:35 am

LUNR

Intuitive Machines (NASDAQ:LUNR) reported Q4 sales of $30.56 million, surpassing the analyst consensus estimate of $22.20 million by 37.66%. However, this represents a 19.55% decrease from the $37.99 million sales reported in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:34 am

CREX

Creative Realities (NASDAQ:CREX) reported Q4 sales of $14.50 million, missing the analyst consensus estimate of $16.00 million by 9.38%, but marking a 38.10% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:32 am

NNDM

Nano Dimension reported a significant improvement in its Q4 earnings, with a 97.06% decrease in losses per share from $(0.34) to $(0.01) YoY, and a 19.42% increase in sales from $12.10M to $14.45M YoY.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:32 am

EXAI

Exscientia reported a Q4 GAAP EPS of $(0.42), missing the $(0.35) estimate. Sales were $3.10M, which may not be directly comparable to the $17.05M estimate.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:30 am

FIVE

Five Below's shares dropped following its Q4 financial results announcement and future guidance. Telsey Advisory Group kept an Outperform rating but reduced the price target from $230 to $220.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:28 am

IMTX

Immatics reported a Q4 GAAP EPS of €(1.20), a decrease from €0.55 YoY. Revenue from collaboration agreements was €54.00M, down from €172.83M YoY. The company's cash and equivalents total €425.9M (~$470.6M), expected to fund operations into 2027.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:27 am

CABA

Cabaletta Bio reported a Q4 EPS of $(0.46), missing the $(0.39) estimate, a significant decrease from the previous year's $0.52 per share. The company has $241.2M in cash and equivalents, expected to fund operations into H1 2026.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:22 am

MIST

Milestone Pharmaceuticals (NASDAQ:MIST) reported a Q4 GAAP EPS of $(0.32), missing the $(0.31) estimate by 3.23%. The company's cash balance of $66M is expected to provide a cash runway into 2026, indicating a slight decrease in losses from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:20 am

CCLD

CareCloud projects its FY2024 sales to be between $118M and $120M, falling short of the consensus estimate of $124.74M. The company also anticipates its adjusted EBITDA to range from $21M to $23M.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:16 am